Enhancement of SARS-CoV-2 vaccine-induced immunity by a Toll-like receptor 7 agonist adjuvant

Signal Transduct Target Ther. 2023 May 24;8(1):213. doi: 10.1038/s41392-023-01485-6.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adjuvants, Immunologic / pharmacology
  • COVID-19 Vaccines* / immunology
  • COVID-19* / prevention & control
  • Humans
  • SARS-CoV-2
  • Toll-Like Receptor 7* / agonists

Substances

  • Adjuvants, Immunologic
  • COVID-19 Vaccines
  • Toll-Like Receptor 7